Epoetin Alfa
- 1 December 1998
- journal article
- Published by Wolters Kluwer Health
- Vol. 357 (357) , 60-67
- https://doi.org/10.1097/00003086-199812000-00009
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidityThe Lancet, 1996
- The Effects of Recombinant Human Erythropoietin on Perioperative Transfusion Requirements in Patients Having a Major Orthopaedic Operation*Journal of Bone and Joint Surgery, 1996
- Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: Preoperative strategies for avoiding allogeneic blood exposureThe American Journal of Surgery, 1995
- Morbidity risk assessment in the surgically anemic patientThe American Journal of Surgery, 1995
- Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapyEuropean Journal of Clinical Investigation, 1994
- Effectiveness of perioperative recombinant human erythropoietin in elective hip replacementThe Lancet, 1993
- The effect of oral iron supplementation on erythropoiesis in autologous blood donorsTransfusion, 1992
- Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]Blood, 1992
- ErythropoietinNew England Journal of Medicine, 1991
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987